Clinical study of Wenxikeli treatment of viral myocarditis.
- Author:
Hong-yan SUN
1
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Drugs, Chinese Herbal; administration & dosage; Female; Humans; Male; Middle Aged; Myocarditis; drug therapy; virology; Treatment Outcome; Young Adult
- From: Chinese Journal of Experimental and Clinical Virology 2009;23(2):144-145
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe Wenxinkeli viral myocarditis clinical efficacy and safety.
METHODS45 patients were randomly divided into two groups. Treatment group given Wenxinkeli (5 g, 3 times a day with warm water) treatment, the control group given adenosine triphosphate, coenzyme A, vitamin C, coenzyme Q10 and other nutrients cardiac drugs, treatment for 4 weeks.
RESULTSThe treatment of clinical symptoms, signs and ECG improvement, restoration of enzyme than the control group, there was a significant difference (P < 0.05).
CONCLUSIONSWenxinkeli ventricular premature treatment of viral myocarditis is effective, and no significant adverse reactions, safety, good.
